These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 15534886)
21. A comment on: statistical evaluation of biomarkers as surrogate endpoints: a literature review by C. J. Weir and R. J. Walley, Statistics in Medicine 2006; 25:183-203. Ditlevsen S; Keiding N Stat Med; 2007 Mar; 26(6):1415-6. PubMed ID: 16847904 [No Abstract] [Full Text] [Related]
23. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
24. Principal stratification with predictors of compliance for randomized trials with 2 active treatments. Roy J; Hogan JW; Marcus BH Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993 [TBL] [Abstract][Full Text] [Related]
25. Analysis of times to repeated events in two-arm randomized trials with noncompliance and dependent censoring. Matsui S Biometrics; 2004 Dec; 60(4):965-76. PubMed ID: 15606417 [TBL] [Abstract][Full Text] [Related]
26. Gatekeeping testing via adaptive alpha allocation. Li JD; Mehrotra DV Biom J; 2008 Oct; 50(5):704-15. PubMed ID: 18932133 [TBL] [Abstract][Full Text] [Related]
27. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses. Atkinson AC; Biswas A Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571 [TBL] [Abstract][Full Text] [Related]
28. Case-only analysis of treatment-covariate interactions in clinical trials. Vittinghoff E; Bauer DC Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319 [TBL] [Abstract][Full Text] [Related]
29. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845 [TBL] [Abstract][Full Text] [Related]
30. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance. Lui KJ; Chang KC Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977 [TBL] [Abstract][Full Text] [Related]
31. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time. Olsen MK; DeLong ER; Oddone EZ; Bosworth HB Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655 [TBL] [Abstract][Full Text] [Related]
32. Comment on: on the design and analysis of randomized clinical trials with multiple endpoints. Lehmacher W; Wassmer G; Reitmeir P Biometrics; 1994 Jun; 50(2):581-3. PubMed ID: 8068855 [No Abstract] [Full Text] [Related]
33. A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial. Mehrotra DV; Li X; Gilbert PB Biometrics; 2006 Sep; 62(3):893-900. PubMed ID: 16984333 [TBL] [Abstract][Full Text] [Related]
34. An urn based covariate adjusted response adaptive allocation design. Bandyopadhyay U; Bhattacharya R Stat Methods Med Res; 2012 Apr; 21(2):135-48. PubMed ID: 22287603 [TBL] [Abstract][Full Text] [Related]
35. [Approach to clinical trial design for acupuncture and moxibustion treatment of stroke]. Hao L; Zhao XF; Li J Zhongguo Zhen Jiu; 2009 Jan; 29(1):56-8. PubMed ID: 19186725 [TBL] [Abstract][Full Text] [Related]
36. A comparison of methods for adaptive treatment selection. Friede T; Stallard N Biom J; 2008 Oct; 50(5):767-81. PubMed ID: 18932136 [TBL] [Abstract][Full Text] [Related]
38. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Freidlin B; Simon R Clin Cancer Res; 2005 Nov; 11(21):7872-8. PubMed ID: 16278411 [TBL] [Abstract][Full Text] [Related]